CHINA PHARMA HOLDINGS, INC. Contract Liability (Deferred Revenue)
CHINA PHARMA HOLDINGS, INC. (CPHI) had Contract Liability (Deferred Revenue) of $153.64 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Current $153.64K.
- 2026-03-31: Contract with Customer, Liability, Current $61.75K.
- 2025-12-31: Contract with Customer, Liability, Current $111.58K.
- 2025-09-30: Contract with Customer, Liability, Current $120.91K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $153.64K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $61.75K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $111.58K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $120.91K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $77.68K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $114.44K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $162.21K 10-K · filed 2026-04-01 |
| 2024-09-30 | $24.92K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $101.06K 10-Q · filed 2024-08-14 |
| 2023-12-31 | $90.51K 10-K · filed 2025-03-31 |
| 2023-09-30 | $172.11K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $61.33K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $136.68K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $520.29K 10-K · filed 2024-04-01 |
| 2022-09-30 | $84.05K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $138.24K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $136.10K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $210.03K 10-K · filed 2023-03-30 |
| 2021-09-30 | $420.04K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $525.58K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $572.01K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $719.79K 10-K · filed 2022-03-30 |
| 2020-09-30 | $640.10K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $592.96K 10-Q · filed 2020-08-13 |
| 2019-12-31 | $505.40K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |